## Abstract The efficacy and safety of pegylated interferon monotherapy in patients with chronic renal failure and chronic hepatitis C remains unclear, although a number of small clinical trials have been published addressing this issue. A systematic review of the literature with a metaβanalysis of
β¦ LIBER β¦
Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials
β Scribed by F. Fabrizi; V. Dixit; P. Messa; P. Martin
- Book ID
- 108886061
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 85 KB
- Volume
- 0
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Pegylated interferon monotherapy of chro
β
Fabrizio Fabrizi; Vivek Dixit; Piergiorgio Messa; Paul Martin
π
Article
π
2010
π
John Wiley and Sons
π
English
β 90 KB
π 2 views
Combined antiviral therapy of hepatitis
β
F. Fabrizi; V. Dixit; P. Martin; P. Messa
π
Article
π
2010
π
John Wiley and Sons
π
English
β 61 KB
Antiviral therapy of hepatitis C in chro
β
F. Fabrizi; S. V. Ganeshan; G. Lunghi; P. Messa; P. Martin
π
Article
π
2008
π
John Wiley and Sons
π
English
β 63 KB
Treatment of chronic hepatitis C in nonr
β
Paul Y. Kwo
π
Article
π
2000
π
Springer
π
English
β 211 KB
Therapy of hepatitis C: Meta-analysis of
β
R L Carithers Jr; S S Emerson
π
Article
π
1997
π
John Wiley and Sons
π
English
β 182 KB
π 2 views
We performed an independent meta-analysis of all available blind, placebo-controlled trials confirmed the efficacy of this randomized clinical trials of interferon alfa-2b in patients with agent in normalizing alanine aminotransferase (ALT) values chronic hepatitis C. Articles published between 1986
Chronic hepatitis C: Interferon retreatm
Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data
β
Calogero CammΓ ; Marco Giunta; Liliana Chemello; Alfredo Alberti; Hidenori Toyoda
π
Article
π
1999
π
John Wiley and Sons
π
English
β 100 KB
π 1 views
the other members of the European Concerted Action on Viral Hepatitis Group are listed in the Appendix.